These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 7517424)
21. A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis. Ugrinovic S; Mertz A; Wu P; Braun J; Sieper J J Immunol; 1997 Dec; 159(11):5715-23. PubMed ID: 9548516 [TBL] [Abstract][Full Text] [Related]
22. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex. Brooks JM; Colbert RA; Mear JP; Leese AM; Rickinson AB J Immunol; 1998 Nov; 161(10):5252-9. PubMed ID: 9820497 [TBL] [Abstract][Full Text] [Related]
23. Yersinia enterocolitica serotype O:3 alters the expression of serologic HLA-B27 epitopes on human monocytes. Wuorela M; Jalkanen S; Kirveskari J; Laitio P; Granfors K Infect Immun; 1997 Jun; 65(6):2060-6. PubMed ID: 9169732 [TBL] [Abstract][Full Text] [Related]
24. In vitro mutagenesis of HLA-B27. Substitution of an unpaired cysteine residue in the alpha 1 domain causes loss of antibody-defined epitopes. Taurog JD; el-Zaatari FA J Clin Invest; 1988 Sep; 82(3):987-92. PubMed ID: 2458390 [TBL] [Abstract][Full Text] [Related]
25. The influence of HLA B27 and interferon-gamma on the invasion and persistence of yersinia in primary human fibroblasts. Huppertz HI; Heesemann J Med Microbiol Immunol; 1996 Nov; 185(3):163-70. PubMed ID: 9007822 [TBL] [Abstract][Full Text] [Related]
26. Unraveling the mystery of HLA-B27 association with human spondyloarthropathies using transgenic and knock out mice. Khare SD; Luthra HS; David CS Semin Immunol; 1998 Feb; 10(1):15-23. PubMed ID: 9529652 [TBL] [Abstract][Full Text] [Related]
27. Recognition of B cells epitopes of the Klebsiella pneumoniae GroEL-like protein by HLA-B27 positive subjects. Cancino-Díaz M; Ayala-Narváez H; Burgos-Vargas R; Selene Reyes-López A; Tovar-Castillo L; Domínguez-López L; Granados Arreola J; Jiménez-Zamudio L; García-Latorre E Microb Pathog; 2000 Apr; 28(4):211-20. PubMed ID: 10764612 [TBL] [Abstract][Full Text] [Related]
28. NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells. Kung SK; Su RC; Graham JJ; Chamberlain JW; Miller RG J Immunol; 1998 Jan; 160(2):674-80. PubMed ID: 9551902 [TBL] [Abstract][Full Text] [Related]
29. A comparison of self-reported joint symptoms following infection with different enteric pathogens: effect of HLA-B27. Schiellerup P; Krogfelt KA; Locht H J Rheumatol; 2008 Mar; 35(3):480-7. PubMed ID: 18203313 [TBL] [Abstract][Full Text] [Related]
30. Overlapping peptide-binding specificities of HLA-B27 and B39: evidence for a role of peptide supermotif in the pathogenesis of spondylarthropathies. Sobao Y; Tsuchiya N; Takiguchi M; Tokunaga K Arthritis Rheum; 1999 Jan; 42(1):175-81. PubMed ID: 9920028 [TBL] [Abstract][Full Text] [Related]
31. Lack of hybridization between Yersinia enterocolitica and HLA-B27 DNA. Viitanen AM; Lahesmaa-Rantala R; Weiss E; Toivanen A J Rheumatol; 1988 Jul; 15(7):1123-5. PubMed ID: 3262758 [TBL] [Abstract][Full Text] [Related]
32. Similar cell surface expression of beta2-microglobulin-free heavy chains by HLA-B27 subtypes differentially associated with ankylosing spondylitis. Vázquez MN; López de Castro JA Arthritis Rheum; 2005 Oct; 52(10):3290-9. PubMed ID: 16200602 [TBL] [Abstract][Full Text] [Related]
33. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. Taurog JD; Maika SD; Simmons WA; Breban M; Hammer RE J Immunol; 1993 May; 150(9):4168-78. PubMed ID: 8473755 [TBL] [Abstract][Full Text] [Related]
34. Bacteria-specific cytotoxic CD8+ T cells: a missing link in the pathogenesis of the HLA-B27-associated spondylarthropathies. Hermann E; Fleischer B; Meyer zum Büschenfelde KH Ann Med; 1994 Oct; 26(5):365-9. PubMed ID: 7530015 [TBL] [Abstract][Full Text] [Related]
36. Mechanisms of Disease: the immunopathogenesis of spondyloarthropathies. Gaston H Nat Clin Pract Rheumatol; 2006 Jul; 2(7):383-92. PubMed ID: 16932724 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of four monoclonal antibodies against HLA-B27 for their reliability in HLA-B27 typing with flow cytometry (FC): comparison with the classic microlymphocytotoxic test (MLCT). Neumüller J; Schwartz DW; Dauber E; Mayr WR Cytometry; 1996 Sep; 26(3):209-15. PubMed ID: 8889393 [TBL] [Abstract][Full Text] [Related]
38. The epitope recognized by pan-HLA class I-reactive monoclonal antibody W6/32 and its relationship to unusual stability of the HLA-B27/beta2-microglobulin complex. Tran TM; Ivanyi P; Hilgert I; Brdicka T; Pla M; Breur B; Flieger M; Ivasková E; Horejsí V Immunogenetics; 2001 Aug; 53(6):440-6. PubMed ID: 11685454 [TBL] [Abstract][Full Text] [Related]
39. Chemical reactivity of an HLA-B27 thiol group. Whelan MA; Archer JR Eur J Immunol; 1993 Dec; 23(12):3278-85. PubMed ID: 8258344 [TBL] [Abstract][Full Text] [Related]